Early Phase Cancer Immunotherapy
| By: | null |
| Publisher: | Springer Nature |
| Print ISBN: | 9783319637563 |
| eText ISBN: | 9783319637570 |
| Edition: | 0 |
| Copyright: | 2018 |
| Format: | Page Fidelity |
Lifetime - $250.80
eBook Features
Instant Access
Purchase and read your book immediately
Read Offline
Access your eTextbook anytime and anywhere
Study Tools
Built-in study tools like highlights and more
Read Aloud
Listen and follow along as Bookshelf reads to you
Details
Table of Contents
This volume, a state-of-the-art review of early phase clinical trials for cancer immunotherapy, discusses biomarker selection, combinatorial strategies and their safety or toxicity, determination of Phase 2 dosing, endpoints in the setting of radiographic pseudoprogression, histology selection, and novel immunotherapeutics as they relate to early phase cancer immunotherapy.